Skip to main content

BU · Burcon NutraScience Corp · Financials

1.01 CAD +0.06 (+6.32%) At close · Nov 6 Intraday price with Plus
Volume · Nov 6 1000 Avg daily vol (3M) 8009

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
171.47K -33.7%
FY2022 Revenue FY2020–FY2022
Net Income
-10.26M -1561.3%
FY2022 Net Income FY2020–FY2022
Operating Margin
-4314.19% -2537.4pp
FY2022 Operating Margin FY2020–FY2022
Operating Cash Flow
-5.91M -95%
FY2022 Operating Cash Flow FY2020–FY2022

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2022 FY2021 FY2020
CAD 171.47K 258.65K 31.13K
CAD 1.85M 414.01K 721.85K
CAD 4.28M 3.65M 2.19M
CAD -7.4M -4.6M -3.72M
CAD 0 0 0
CAD -10.26M -617.49K -4.63M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current lease liabilities 2022-03-31 CAD 14,397 20-F filed 2022-08-01
Noncurrent lease liabilities 2022-03-31 CAD 58,742 20-F filed 2022-08-01
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.